Ariad Opts-in To Co-Promote mTOR With Merck
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech takes advantage of the Big Pharma's financial wherewithal and regulatory/market expertise to build out its own commercial infrastructure.